Edit Entry

R. Brooks Robey, M.D.

Associate Professor of Medicine
Associate Professor of Physiology and Neurobiology
Associate Chief of Staff for Research, White River Junction VAMC
Founding Chief, Section of Nephrology and Hypertension, White River Junction VAMC
Inaugural Director, Northern New England Research Consortium (White River Junction VAMC [VT], Manchester VAMC [NH], VA Maine HCS [ME], and Central Western Massachusetts VAMC [MA])

Physiology and Neurobiology

B.S. with Honors in Chemical Biology, Rhodes College (1981)
M.D., University of Arkansas for Medical Sciences (1985)
Intern, Internal Medicine, University of Arkansas (1985-1986)
Resident, Internal Medicine, University of Arkansas (1986-1988)
Research Fellow, Molecular Physiology, LKEM, NHLBI, NIH (1988-1991)
Clinical Fellow, Nephrology, Vanderbilt University (1991-1994)
Research Fellow, Molecular Physiology, Vanderbilt University (1992-1996)

Program in Experimental and Molecular Medicine


Contact Information:

c/o WRJVAMC R&D Svc (151)
215 N Main St
White River Jct VT 05009-0001

Office: WRVAMC - B44/2-141
Phone: 802.296.5131
Fax: 802.296.6308
Email: R.Brooks.Robey@Dartmouth.edu

Asst. Phone: 802.295.9363 x5374

Courses Taught:

PEMM 101
Medical Physiology
Scientific Basis of Medicine (FEK)

Selected Publications:


Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead.
Goodson WH 3rd, Lowe L, Carpenter DO, Gilbertson M, Manaf Ali A, Lopez de Cerain Salsamendi A, Lasfar A, Carnero A, Azqueta A, Amedei A, Charles AK, Collins AR, Ward A, Salzberg AC, Colacci A, Olsen AK, Berg A, Barclay BJ, Zhou BP, Blanco-Aparicio C, Baglole CJ, Dong C, Mondello C, Hsu CW, Naus CC, Yedjou C, Curran CS, Laird DW, Koch DC, Carlin DJ, Felsher DW, Roy D, Brown DG, Ratovitski E, Ryan EP, Corsini E, Rojas E, Moon EY, Laconi E, Marongiu F, Al-Mulla F, Chiaradonna F, Darroudi F, Martin FL, Van Schooten FJ, Goldberg GS, Wagemaker G, Nangami GN, Calaf GM, Williams G, Wolf GT, Koppen G, Brunborg G, Lyerly HK, Krishnan H, Ab Hamid H, Yasaei H, Sone H, Kondoh H, Salem HK, Hsu HY, Park HH, Koturbash I, Miousse IR, Scovassi AI, Klaunig JE, Vondrańćek J, Raju J, Roman J, Wise JP Sr, Whitfield JR, Woodrick J, Christopher JA, Ochieng J, Martinez-Leal JF, Weisz J, Kravchenko J, Sun J, Prudhomme KR, Narayanan KB, Cohen-Solal KA, Moorwood K, Gonzalez L, Soucek L, Jian L, D'Abronzo LS, Lin LT, Li L, Gulliver L, McCawley LJ, Memeo L, Vermeulen L, Leyns L, Zhang L, Valverde M, Khatami M, Romano MF, Chapellier M, Williams MA, Wade M, Manjili MH, Lleonart ME, Xia M, Gonzalez MJ, Karamouzis MV, Kirsch-Volders M, Vaccari M, Kuemmerle NB, Singh N, Cruickshanks N, Kleinstreuer N, van Larebeke N, Ahmed N, Ogunkua O, Krishnakumar PK, Vadgama P, Marignani PA, Ghosh PM, Ostrosky-Wegman P, Thompson PA, Dent P, Heneberg P, Darbre P, Sing Leung P, Nangia-Makker P, Cheng QS, Robey RB, Al-Temaimi R, Roy R, Andrade-Vieira R, Sinha RK, Mehta R, Vento R, Di Fiore R, Ponce-Cusi R, Dornetshuber-Fleiss R, Nahta R, Castellino RC, Palorini R, Abd Hamid R, Langie SA, Eltom SE, Brooks SA, Ryeom S, Wise SS, Bay SN, Harris SA, Papagerakis S, Romano S, Pavanello S, Eriksson S, Forte S, Casey SC, Luanpitpong S, Lee TJ, Otsuki T, Chen T, Massfelder T, Sanderson T, Guarnieri T, Hultman T, Dormoy V, Odero-Marah V, Sabbisetti V, Maguer-Satta V, Rathmell WK, Engstrom W, Decker WK, Bisson WH, Rojanasakul Y, Luqmani Y, Chen Z, Hu Z
Carcinogenesis. 2015 Jun;36 Suppl 1:S254-96. doi: 10.1093/carcin/bgv039.
PMID: 26106142

Metabolic reprogramming and dysregulated metabolism: cause, consequence and/or enabler of environmental carcinogenesis?
Robey RB, Weisz J, Kuemmerle NB, Salzberg AC, Berg A, Brown DG, Kubik L, Palorini R, Al-Mulla F, Al-Temaimi R, Colacci A, Mondello C, Raju J, Woodrick J, Scovassi AI, Singh N, Vaccari M, Roy R, Forte S, Memeo L, Salem HK, Amedei A, Hamid RA, Williams GP, Lowe L, Meyer J, Martin FL, Bisson WH, Chiaradonna F, Ryan EP
Carcinogenesis. 2015 Jun;36 Suppl 1:S203-31. doi: 10.1093/carcin/bgv037.
PMID: 26106140

Varenicline for smoking reduction prior to cessation.
Robey RB, Block CA, O'Rourke DJ
JAMA. 2015 Jun 9;313(22):2285. doi: 10.1001/jama.2015.4978.
PMID: 26057293

Cyclical dehydration-induced renal injury and Mesoamerican nephropathy: as sweet by any other name?
Robey RB
Kidney Int. 2014 Aug;86(2):226-9. doi: 10.1038/ki.2014.47.
PMID: 25079017

Changing the terminology of cancer.
Robey RB
JAMA. 2014 Jan 8;311(2):202-3. doi: 10.1001/jama.2013.283382.
PMID: 24399567

Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer.
Patra KC, Wang Q, Bhaskar PT, Miller L, Wang Z, Wheaton W, Chandel N, Laakso M, Muller WJ, Allen EL, Jha AK, Smolen GA, Clasquin MF, Robey RB, Hay N
Cancer Cell. 2013 Aug 12;24(2):213-28. doi: 10.1016/j.ccr.2013.06.014. Epub 2013 Aug 1.
PMID: 23911236

Peptides modeled on the RGG domain of AUF1/hnRNP-D regulate 3' UTR-dependent gene expression.
Fellows A, Deng B, Mierke DF, Robey RB, Nichols RC
Int Immunopharmacol. 2013 Sep;17(1):132-41. doi: 10.1016/j.intimp.2013.05.014. Epub 2013 Jun 5.
PMID: 23747316

"Does sunscreen promote hypertension?" and other questions. Novel interactions between vitamin D and the renin-angiotensin axis. Focus on "The world pandemic of vitamin D deficiency could possibly be explained by cellular inflammatory response activity induced by the renin-angiotensin system".
Robey RB, Crane-Godreau MA
Am J Physiol Cell Physiol. 2013 Jun 1;304(11):C1040-1. doi: 10.1152/ajpcell.00090.2013. Epub 2013 Apr 10.
PMID: 23576577

Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease.
Robey RB, O'Rourke DJ
Ann Intern Med. 2012 Aug 21;157(4):302-3; author reply 303-4. doi: 10.7326/0003-4819-157-4-201208210-00024.
PMID: 22910952

Potassium levels after acute myocardial infarction.
Robey RB
JAMA. 2012 Apr 18;307(15):1578-9; author reply 1579-80. doi: 10.1001/jama.2012.486.
PMID: 22511680